Validation of a population pharmacokinetic/pharmacodynamic model for 5 -reductase inhibitors

By Trouw R.A.J.   De Wit M.J.   Olsson Gisleskog P.   Hermann D.   Hammarlund-Udenaes M.   Karlsson M.O.  

European Journal of Pharmaceutical Sciences, Vol. 8, Iss. 4, 1999-08 ,pp. : 291-299

Elsevier

Access to resources Recommend Favorite

Population Pharmacokinetic/Pharmacodynamic Modelling of the Analgesic Effects of Tramadol in Pediatrics

By Garrido María   Habre Walid   Rombout Ferdinand   Trocóniz Iñaki  

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 2014-2023

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic-Pharmacodynamic Relationship of Dobutamine and Heart Rate, Stroke Volume and Cardiac Output in Healthy Volunteers

By Ahonen Jouni  

Clinical Drug Investigation, Vol. 28, Iss. 2, 2008-01 ,pp. : 121-127

Adis International

Access to resources Recommend Favorite

Pharmacokinetic–Pharmacodynamic Modeling of Doxacurium: Effect of Input Rate

By Zhu Yali   Audibert Gérald   Donati François   Varin France  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 1, 1997-02 ,pp. : 23-37

Springer Publishing Company

Access to resources Recommend Favorite

Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic–pharmacodynamic modeling of biologics

By Gibiansky Leonid   Gibiansky Ekaterina  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 7, 2009-07 ,pp. : 803-812

Informa Healthcare

Access to resources Recommend Favorite